Who Owns Whitehawk Therapeutics Stock?
NASDAQ: WHWKHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 3.52 0.00%
Ownership breakdown
- Held by institutions
- 81.08%
- Held by insiders
- 12.62%
- Institutional holders
- 107
- Institutions 81.1%
- Insiders 12.6%
- Public and other 6.3%
Who owns Whitehawk Therapeutics stock?
Institutional investors own about 81.1% of Whitehawk Therapeutics's shares, spread across 107 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 12.62% of WHWK.
The largest institutional holders are Yu Fan (8.53%), Acuta Capital Partners LLC (8.22%) and QVT Financial LP (8.10%). Together, the top 10 institutions control 58.0% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their WHWK positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of WHWK
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Yu Fan | 4.86M | 8.53% | +134.8% |
| Acuta Capital Partners LLC | 4.69M | 8.22% | +37.4% |
| QVT Financial LP | 4.62M | 8.10% | 0.0% |
| Montanova Capital LLC | 4.30M | 7.54% | +16.2% |
| Orbimed Advisors LLC. | 3.93M | 6.90% | -5.6% |
| Avoro Capital Advisors LLC | 2.85M | 5.00% | 0.0% |
| Siren, L.L.C. | 2.34M | 4.10% | +12.3% |
| Kvp Capital Advisors, LP | 2.17M | 3.80% | 0.0% |
| Blackrock Inc. | 1.92M | 3.37% | +447.2% |
| Vanguard Capital Management LLC | 1.39M | 2.44% | +5.5% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of WHWK
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 887.97K | 1.56% |
| iShares Trust-iShares Russell 2000 ETF | 723.10K | 1.27% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 470.85K | 0.83% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 352.17K | 0.62% |
| iShares Trust-iShares Russell 2000 Value ETF | 310.11K | 0.54% |
| Bridgeway Funds, Inc.-Ultra-Small Company Fund | 165.28K | 0.29% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 146.48K | 0.26% |
| iShares Trust-iShares Micro-Cap ETF | 109.85K | 0.19% |
| SCHWAB CAPITAL TRUST-Schwab Small-Cap Index Fund | 78.83K | 0.14% |
| American Century ETF Trust-Avantis U.S. Small Cap Equity ETF | 62.72K | 0.11% |
Frequently asked questions
Who is the largest shareholder of Whitehawk Therapeutics?
Yu Fan is the largest institutional shareholder of WHWK, owning 8.53% of shares outstanding (4.86M shares) as of its latest 13F filing.
What percentage of Whitehawk Therapeutics is owned by institutions?
Institutions own about 81.1% of WHWK shares and 92.8% of the public float.
How much of Whitehawk Therapeutics do insiders own?
Insiders, such as officers and directors, own about 12.62% of WHWK shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.